Follow
Vinayak Khairnar
Vinayak Khairnar
Unknown affiliation
Verified email at aurigene.com
Title
Cited by
Cited by
Year
Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors
S Rudra, N Gupta, LK Baregama, R Agarwal, VV Khairnar, MR Ramaiah, ...
US Patent 8,420,666, 2013
82013
Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
VP Palle, S Balachandran, N Gupta, N Muthukamal, MR Ramaiah, ...
US Patent App. 11/815,695, 2009
82009
Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors
S Rudra, N Gupta, LK Baregama, R Agarwal, VV Khairnar, MR Ramaiah, ...
32010
Identification of novel covalent inhibitors of K-Ras G12C that are efficacious in a xenograft model of NSCLC
LK Satyam, D Chikkanna, VV Khairnar, S Reddy, V Durgaprasad, ...
Cancer Research 76 (14_Supplement), 339-339, 2016
22016
Abstract A72: novel NAMPT inhibitors for the treatment of pancreatic cancer
D Chikanna, A Lakshminarasimhan, V Khairnar, S Panigrahi, ...
Molecular Cancer Research 14 (1_Supplement), A72-A72, 2016
22016
4,5-DIHYDROISOXAZOLE DERIVATIVES AS NAMPT INHIBITORS
D CHIKKANNA, V (IN). KHAIRNAR, SK (IN). PANIGRAHI, ( IN)
WO Patent WO/2014/111,871, 2014
22014
Inhibitors of phosphodiesterase type-IV
S Rudra, N Gupta, LK Baregama, R Agarwal, VV Khairnar, S Chakladar, ...
22008
Substituted alkynylene compounds as anticancer agents
D Chikkanna, VV Khairnar, M Ramachandra, LK Satyam
US Patent 11,633,394, 2023
12023
Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
S Rudra, N Gupta, LK Baregama, R Agarwal, VV Khairnar, MR Ramaiah, ...
12008
Substituted Alkynylene Compounds As Anticancer Agents
D Chikkanna, VV Khairnar, M Ramachandra, LK Satyam
US Patent App. 18/120,149, 2023
2023
Discovery and preclinical evaluation of a novel covalent inhibitor of FABP5 for cancer therapy
D Chikkanna, LK Satyam, SK Pnaigrahi, V Khairnar, M Pothuganti, ...
Cancer Research 81 (13_Supplement), 1266-1266, 2021
2021
Potent small molecule compounds that selectively inhibit proliferation of ABC-DLBCL cell lines
LK Satyam, D Chikkanna, V Khairnar, M Pothuganti, S Panigrahi, ...
Cancer Research 77 (13_Supplement), 5108-5108, 2017
2017
Discovery of dihydro-isoxazole derivatives as novel inhibitors of NAMPT for the treatment of multiple myeloma
D Chikkanna, A Lakshminarasimhan, V Khairnar, S Panigrahi, ...
Cancer Research 75 (15_Supplement), 5367-5367, 2015
2015
Cyclic Urea Derivatives As Androgen Receptor Antagonists
MG Bock, D Chikkanna, M Gerspacher, V Khairnar, B Lagu, C Pandit
US Patent App. 14/361,728, 2014
2014
FUSED HETEROCYCLYL DERIVATIVES AS NAMPT INHIBITORS
V KHAIRNAR, D (IN) ,CHIKKANNA, ( IN).
WO Patent WO/2014/141,035, 2014
2014
Novel inhibitors of nicotinamide phosphoribosyl transferase and their evaluation in combination with bortezomib.
M Ramachandra, A Lakshminarasimhan, D Chikkanna, V Khairnar, ...
Journal of Clinical Oncology 32 (15_suppl), e19566-e19566, 2014
2014
Abstract B210: Novel inhibitors of nicotinamide phosphoribosyl transferase and their evaluation in combination with bortezomib.
D Chikkanna, A Lakshminarasimhan, V Khairnar, S Panigrahi, ...
Molecular Cancer Therapeutics 12 (11_Supplement), B210-B210, 2013
2013
Composto, composição farmacêutica, método para tratar, prevenir, inibir ou suprimir uma condição inflamatória ou doença ou doenças do sistema nervoso central e método para a …
S Rudra, N Gupta, LK Baregama, R Agarwal, VV Khairnar, S Chakladar, ...
2013
Novel inhibitors of nicotinamide phosphoribosyl transferase (NAMPT).
M Ramachandra, C Pandit, H Subramanya, D Chikkanna, ...
Cancer Research 73 (8_Supplement), 5389-5389, 2013
2013
Abstract 5389: Novel inhibitors of nicotinamide phosphoribosyl transferase (NAMPT).
RR Murali Ramachandra, Chetan Pandit, Hosahalli Subramanya, Dinesh Chikkanna ...
Proceedings of the 104th Annual Meeting of the American Association for …, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20